======= CYP4V2 ======= == Gene Information == * **Official Symbol**: CYP4V2 * **Official Name**: cytochrome P450 family 4 subfamily V member 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=285440|285440]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6ZWL3|Q6ZWL3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CYP4V2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP4V2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608614|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the cytochrome P450 hemethiolate protein superfamily which are involved in oxidizing various substrates in the metabolic pathway. It is implicated in the metabolism of fatty acid precursors into n-3 polyunsaturated fatty acids. Mutations in this gene result in Bietti crystalline corneoretinal dystrophy. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Omega-hydroxylase that oxidizes medium-chain saturated fatty acids and polyunsaturated omega-3 fatty acids, and which plays a role in fatty acid and steroid metabolism in the eye (PubMed:19661213, PubMed:22772592). Catalyzes the omega- hydroxylation of medium-chain saturated fatty acids such as laurate, myristate and palmitate in an NADPH-dependent pathway. The substrate specificity is higher for myristate > laurate > palmitate (C14>C16>C12) (PubMed:19661213). Acts as a polyunsaturated omega-3 fatty acids hydroxylase by mediating oxidation of docosahexaenoate (DHA) to 22-hydroxydocosahexaenoate (PubMed:22772592). Also produces some 21-hydroxydocosahexaenoate. Also converts eicosapentaenoate (EPA) to 20- hydroxyeicosapentaenoate (20-OH-EPA) (PubMed:22772592). {ECO:0000269|PubMed:19661213, ECO:0000269|PubMed:22772592}. |p450| |fatty acid omega-oxidation| |oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen| |monooxygenase activity| |fatty acid oxidation| |lipid oxidation| |retinoid metabolic process| |diterpenoid metabolic process| |terpenoid metabolic process| |iron ion binding| |sterol metabolic process| |isoprenoid metabolic process| |heme binding| |lipid modification| |visual perception| |sensory perception of light stimulus| |steroid metabolic process| |fatty acid metabolic process| |organic hydroxy compound metabolic process| |monocarboxylic acid metabolic process| |carboxylic acid metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |sensory perception| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |nervous system process| |small molecule metabolic process| |system process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8121 * **Expression level (log2 read counts)**: 3.96 {{:chemogenomics:nalm6 dist.png?nolink |}}